Otsuka receives US FDA accelerated approval for Voyxact to reduce proteinuria in adults with IgAN: Princeton, New Jersey Thursday, November 27, 2025, 12:00 Hrs [IST] Otsuka Pharma ...

The Food and Drug Administration (FDA) has granted accelerated approval to Voyxact ® (sibeprenlimab-szsi) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for ...

“This study adds to the growing body of evidence that diets rich in polyphenols – naturally occurring antioxidants and plant compounds found in foods such as onions, peppers, garlic, nuts, wholegrains ...

Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...

The role of the liver in our body is vital. It acts as the body’s natural detoxifier, filtering out toxins from the blood, ...

The alkaline diet, popular for its cancer prevention claims, emphasizes fruits and vegetables while limiting meats and ...

Exclusive: Patient said she suffered nightmares following stay at under-fire NHS trust criticised by health watchdog over ...

Rates of cutaneous manifestations at presentation in the rest ranged from 20% of patients with microscopic polyangiitis to 97% of patients with immunoglobulin-A vasculitis (IgAV). In between, ...

A new FDA approval for a first-in-class drug has vaulted Otsuka into immunoglobulin A nephropathy (IgAN), an increasingly competitive kidney disease field targeted by multiple biopharma companies.

Yet only about 22% was formally collected and recycled. At the current pace, the figure will exceed 80 million tons by 2030, ...

Taking moderate amounts of lean beef in a healthy Mediterranean diet does not increase heart disease, while also enhancing ...

Eating moderate amounts of lean beef as part of a Mediterranean diet does not increase an emerging risk factor for ...